We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Former Head of Rare Diseases and Diversity and Inclusion Co-Chair, Pfizer
Owen draws on his experience as a leader, driven to address inequality and unfairness through his work in rare diseases, bringing breakthrough treatments to patients, and leading work to improve diversity, inclusion, and belonging for people at work.
His leadership experience is built across the UK, Western Europe, and emerging markets in central and eastern Europe. He has a proven track record of positive culture and delivering results through building and leading highly effective and diverse teams who draw on their differences for more creative thought.
Owen is Chair of the Advanced Therapeutic Medicinal Products (ATMP) workstream for ABPI on Cell and Gene Therapy.
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now